Intensity-Modulated Radiation Therapy (IMRT) in the Treatment of Non-Anaplastic Non-Medullary Thyroid Cancer

Completed · Phase 2

Conditions studied: Thyroid Cancer

In brief

The purpose of this Phase 2 study is to find out what effect, good and/or bad, external beam radiation therapy, has on the patient and their thyroid cancer where surgery is not an option or where despite surgery, the disease is still present.

Key facts

Study ID

NCT01882816

Run by

Memorial Sloan Kettering Cancer Center

People needed

27

Starts

2013-06-13

Expected to finish

2021-11-04

Last updated by the study team

2022-12-29

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Pathologically confirmed diagnosis of non-anaplastic non-medullary thyroid cancer that is either grossly recurrent after surgery or unresectable with or without metastatic disease.
• Age ≥18 years
• Karnofsky performance status ≥70%
• Men and women of childbearing potential must be willing to consent to using effective contraception while on treatment and for at least 3 months after treatment.
• Patients must have ability to understand and the willingness to sign a written informed consent document.

You may not qualify if…

• Women who are pregnant or lactating
• Inability to comply with study and/or follow-up procedures

Where it is running

• Memorial Sloan Kettering Basking Ridge — Basking Ridge, New Jersey, United States
• Memorial Sloan Kettering Monmouth — Middletown, New Jersey, United States
• Memorial Sloan Kettering Commack — Commack, New York, United States
• Memorial Sloan Kettering Westchester — Harrison, New York, United States
• Memorial Sloan Kettering Cancer Center — New York, New York, United States
• Memorial Sloan Kettering Rockville Centre — Rockville Centre, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.